Acido pamidronico [INN-Spanish]
Acido pamidronico [INN-Spanish] Brand names, Acido pamidronico [INN-Spanish] Analogs
Acido pamidronico [INN-Spanish] Brand Names Mixture
- No information avaliable
Acido pamidronico [INN-Spanish] Chemical_Formula
C3H11NO7P2
Acido pamidronico [INN-Spanish] RX_link
http://www.rxlist.com/cgi/generic/aredia.htm
Acido pamidronico [INN-Spanish] fda sheet
Acido pamidronico [INN-Spanish] msds (material safety sheet)
Acido pamidronico [INN-Spanish] Synthesis Reference
No information avaliable
Acido pamidronico [INN-Spanish] Molecular Weight
235.07 g/mol
Acido pamidronico [INN-Spanish] Melting Point
No information avaliable
Acido pamidronico [INN-Spanish] H2O Solubility
No information avaliable
Acido pamidronico [INN-Spanish] State
No information avaliable
Acido pamidronico [INN-Spanish] LogP
-3.048
Acido pamidronico [INN-Spanish] Dosage Forms
Liquid; Powder for solution; Solution
Acido pamidronico [INN-Spanish] Indication
For the treatment of moderate or severe hypercalcemia associated with malignancy
Acido pamidronico [INN-Spanish] Pharmacology
Pamidronate is in a class of drugs called bisphosphonates. Pamidronate reduces breakdown of the bones. Pamidronate is used in the treatment of Paget's disease of bone; to reduce high levels of calcium in the blood associated with malignancy (cancer); and to reduce the breakdown of bone due to metastases of breast cancer or multiple myeloma.
Acido pamidronico [INN-Spanish] Absorption
No information avaliable
Acido pamidronico [INN-Spanish] side effects and Toxicity
Side effects include an allergic reaction, kidney problems, seizures, low levels of calcium, magnesium, or phosphorus in the blood
Acido pamidronico [INN-Spanish] Patient Information
No information avaliable
Acido pamidronico [INN-Spanish] Organisms Affected
Humans and other mammals
![Acido_pamidronico_[INN-Spanish]](/images/rx/APRD01161.gif)
